Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59.6M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
16.4M
-
Shares change
-
-731K
-
Total reported value, excl. options
-
$148M
-
Value change
-
-$5.57M
-
Put/Call ratio
-
1.67
-
Number of buys
-
45
-
Number of sells
-
-31
-
Price
-
$9.03
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2019
95 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2019.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.4M shares
of 59.6M outstanding shares and own 27.45% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.09M shares), FMR LLC (1.9M shares), 683 Capital Management, LLC (1.8M shares), BlackRock Inc. (1.34M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.12M shares), SPHERA FUNDS MANAGEMENT LTD. (1.07M shares), VANGUARD GROUP INC (1.07M shares), Prosight Management, LP (583K shares), Knoll Capital Management, LP (484K shares), and MILLENNIUM MANAGEMENT LLC (386K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.